Skip to main content
SpringerLink
Log in

Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

We evaluated the sensitivity and specificity of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography (CEUS) using perflubutane microbubbles (Sonazoid) in comparison with conventional B-mode ultrasonography (US) for the detection of hepatocellular carcinoma (HCC) nodules.

Methods

A total of 100 treatment-naïve HCC patients admitted at our hospital between December 2007 and June 2009 were consecutively enrolled. The sensitivity and specificity of conventional and contrast-enhanced US were evaluated on a liver segment basis using dynamic CT as a reference standard. Movie files of conventional and enhanced US were stored separately for each segment (e.g., lateral, medial, anterior, and posterior) and reviewed randomly by two blinded readers.

Results

A total of 138 HCC nodules (mean diameter 20.3 mm) were detected in 123 of 400 segments. Detection sensitivity of B-mode US was 0.837 for reader A and 0.846 for reader B, and that of CEUS was 0.732 for reader A and 0.831 for reader B. Specificity of B-mode US was 0.902 for reader A and 0.949 for reader B, and that of CEUS was 0.986 for reader A and 0.978 for reader B. CEUS false positives were mainly due to misidentification of hepatic cysts. A significant proportion of false-negative nodules are hyperechoic in B-mode US, likely because echogenicity hampers visualization of the defect in Kupffer imaging.

Conclusions

Kupffer imaging by CEUS with Sonazoid showed very high specificity but rather mediocre sensitivity for HCC detection. CEUS is highly suitable for confirmatory diagnosis of HCC; however, caution should be exercised in reaching a diagnosis based only on CEUS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AFP:

Alphafetoprotein

CEUS:

Contrast-enhanced ultrasonography

Conventional B-mode US:

Conventional B-mode ultrasonography

CT:

Computed tomography

CTAP:

CT during arterial portography

CTHA:

CT during hepatic arteriography

CI:

Confidence interval

Gd-EOB-DTPA:

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid

HBsAg:

Hepatitis B surface antigen

HCC:

Hepatocellular carcinoma

HCVAb:

Hepatitis C virus antibody

MI:

Mechanical index

STARD:

The standards of reporting diagnostic accuracy

SPIO-MRI:

Superparamagnetic iron oxide in magnetic resonance imaging

US:

Ultrasonography

References

  1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–17.

    Article  PubMed  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

    Google Scholar 

  3. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 Suppl 1):S27–34.

    Article  PubMed  Google Scholar 

  4. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325(10):675–80.

    Article  PubMed  CAS  Google Scholar 

  5. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol. 2006;12(5):828–9.

    PubMed  Google Scholar 

  6. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421–30.

    Article  PubMed  CAS  Google Scholar 

  7. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33(2):318–25.

    Article  PubMed  Google Scholar 

  8. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology. 1996;24(4):807–12.

    Article  PubMed  CAS  Google Scholar 

  9. Shunichi S, Hiroko I, Fuminori M, Waki H. Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles. Ultrasound Med Biol. 2009;35(11):1819–27.

    Article  PubMed  Google Scholar 

  10. Kindberg GM, Tolleshaug H, Roos N, Skotland T. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res. 2003;312(1):49–54.

    PubMed  Google Scholar 

  11. Hatanaka K, Kudo M, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology. 2008;75(Suppl 1):42–7.

    Article  PubMed  Google Scholar 

  12. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193(1):86–95.

    Article  PubMed  Google Scholar 

  13. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138(1):W1–12.

    PubMed  Google Scholar 

  14. The committee for revision of the clinical practice guidelines for hepatocellular carcinoma. Clinical practice guidelines for hepatocellular carcinoma—The Japan Society of Hepatology 2009 update. Hepatol Res. 2010;40(s1):16–47 (Practice Guideline).

    Google Scholar 

  15. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–5.

    Article  PubMed  CAS  Google Scholar 

  16. Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess. 2007;11(34):1–206.

    PubMed  CAS  Google Scholar 

  17. Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol. 2007;42(9):643–51.

    Article  PubMed  CAS  Google Scholar 

  18. Saini S, Stark DD, Hahn PF, Bousquet JC, Introcasso J, Wittenberg J, et al. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology. 1987;162(1 Pt 1):217–22.

    PubMed  CAS  Google Scholar 

  19. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology. 1988;168(2):297–301.

    PubMed  CAS  Google Scholar 

  20. Asahina Y, Izumi N, Uchihara M, Noguchi O, Ueda K, Inoue K, et al. Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography. Hepatol Res. 2003;27(3):196–204.

    Article  PubMed  Google Scholar 

  21. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32(2):205–12.

    Article  PubMed  CAS  Google Scholar 

  22. Blomley MJ, Albrecht T, Cosgrove DO, Patel N, Jayaram V, Butler-Barnes J, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology. 1999;210(2):409–16.

    PubMed  CAS  Google Scholar 

  23. Numata K, Morimoto M, Ogura T, Sugimori K, Takebayashi S, Okada M, et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med. 2008;27(3):395–406.

    PubMed  Google Scholar 

  24. Luo W, Numata K, Morimoto M, Kondo M, Takebayashi S, Okada M, et al. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT. Radiology. 2009;251(1):287–95.

    Article  PubMed  Google Scholar 

  25. Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Hepatol Res. 2007;37(Suppl 2):S193–9.

    Article  PubMed  Google Scholar 

  26. Hohmann J, Albrecht T, Hoffmann CW, Wolf KJ. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol. 2003;46(2):147–59.

    Article  PubMed  CAS  Google Scholar 

  27. Hirokawa Y, Isoda H, Maetani YS, Arizono S, Shimada K, Okada T, et al. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique—evaluation of SPIO-enhanced T2-weighted MR images. Radiology. 2009;251(2):388–97.

    Article  PubMed  Google Scholar 

  28. Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, Franz M, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol. 2003;13(2):262–72.

    PubMed  Google Scholar 

  29. Edey AJ, Ryan SM, Beese RC, Gordon P, Sidhu PS. Ultrasound imaging of liver metastases in the delayed parenchymal phase following administration of Sonazoid using a destructive mode technique (Agent Detection Imaging). Clin Radiol. 2008;63(10):1112–20.

    Article  PubMed  CAS  Google Scholar 

  30. Kudo M. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology. 2010;78(Suppl 1):87–93.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Eriko Goto, Ryota Masuzaki, Ryosuke Tateishi, Yuji Kondo, Jun Imamura, Tadashi Goto, Shuichiro Shiina, Haruhiko Yoshida & Kazuhiko Koike

  2. Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan

    Hitoshi Ikeda

  3. Department of Radiology, The University of Tokyo, Tokyo, Japan

    Masaaki Akahane

  4. Yamanashi Prefectural Hospital Organization, Kofu, Japan

    Masao Omata

Authors
  1. Eriko Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryota Masuzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryosuke Tateishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuji Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Imamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tadashi Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hitoshi Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masaaki Akahane
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shuichiro Shiina
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masao Omata
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Haruhiko Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kazuhiko Koike
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryosuke Tateishi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goto, E., Masuzaki, R., Tateishi, R. et al. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. J Gastroenterol 47, 477–485 (2012). https://doi.org/10.1007/s00535-011-0512-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-011-0512-9

Keywords

Search

Navigation